Gantenbein, Andreas R. http://orcid.org/0000-0001-5686-0200
Bonvin, Christophe
Kamm, Christian P.
Schankin, Christoph J.
Zecca, Chiara
Zieglgänsberger, Dominik
Merki-Feld, Gabriele Susanne
Pohl, Heiko
Rudolph, Nicole
Ryvlin, Philippe
Agosti, Reto
Schäfer, Elisabeth
Meyer, Ina
Kulartz-Schank, Monika
Arzt, Michael E.
Funding for this research was provided by:
Novartis
University of Zurich
Article History
Received: 5 March 2024
Revised: 21 May 2024
Accepted: 22 May 2024
First Online: 13 June 2024
Declarations
:
: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: ARG reports honorarium and/or consulting fees from Allergan, Almirall, Amgen, Curatis, Eli Lilly, Grünenthal, Lundbeck, Novartis and TEVA Pharmaceuticals. RA report honoraria for speaker, advisory board and/or investigator activities from Allergan, Almogran, Drossa Pharma, Eli Lilly, Lundbeck, Medical Tribune (Biomed, Schwabe), Merz, Novartis and TEVA. CPK has received honoraria for lectures as well as research support from Almirall, Biogen, Celgene, Eli Lilly, Janssen, Merck, Novartis, Roche, Sanofi Genzyme, Swiss MS Society (SMSG) and Teva. GSM-F reports honoraria for advisor and speaker activities from Novartis. HP received honoraria from Eli Lilly, speaker fees from Novartis and TEVA Pharmaceuticals as well as fundings from the Werner Dessauer Stiftung. PR's institution has received fees for his participation to advisory boards or speaker fees from Eli-Lilly, Lundbeck Novartis, and Teva pharmaceuticals. CJS received consulting, advisory boards and speaker fees as well as travel support from Abbvie, Allergan, Almirall, Amgen, Eli Lilly, Grünenthal, Lundbeck, MindMed, Novartis, TEVA Pharmaceuticals; part-time-employee at Zynnon, and has received funding from TEVA Pharmaceuticals, Baasch-Medicus Foundation Deutsche Migräne- und Kopfschmerzgesellschaft () and Swiss Heart Foundation outside the submitted work. CB, DZ and NR declared no conflict of interests. CZ has received honoraria for advisory boards from the Swiss MS Society. Ente Ospedaliero Cantonale (employer) received compensation for C.Z.’s speaking activities, consulting fees, or research grants from Almirall, Biogen Idec, Bristol Meyer Squibb, Lundbeck, Merck, Novartis, Sanofi, Teva Pharma, Roche. CZ is recipient of a grant for senior researchers provided by AFRI (Area Formazione accademica, Ricerca ed Innovazione). ES, IM, MKS and MEA are employees of Novartis Pharma Schweiz AG or were employees of Novartis Pharma Schweiz AG during conduct of this study.
: In adherence to the principles of open science and transparency, the data supporting the findings of this study are available to researchers on reasonable request for purposes of replication or data re-use.
: All authors read and approved the final manuscript.
: The SQUARE study was approved by the competent lead ethics committee (Ethikkommission Nordwest- und Zentralschweiz EKNZ) in February 2019 and can therefore be found under BASEC ID 2018–02375 in the Registry of All Projects in Switzerland (RAPS).